Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Rafinlar 75mg Capsule
Manufacturer/Marketed By : NOVARTIS INDIA LTD
$512.13 $479.18
Sidmex Inovia offers bulk export supply of Rafinlar 75mg Capsule (DABRAFENIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...
DABRAFENIB
Active Pharmaceutical Ingredient
Rafinlar 75mg Capsule
$512.13
$479.18
Sidmex Inovia offers bulk export supply of Rafinlar 75mg Capsule (DABRAFENIB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Rafinlar 50 mg Capsule
Rafinlar 75mg Capsule contains an active molecule named as Dabrafenib. It is used to treat skin cancer called melanoma which cannot be removed by surgery or has spread to other body parts. Also prevents melanoma from returning after being removed from surgery. This medication is used to treat a kind of lung cancer called non-small cell lung cancer (NSCLC). It is only used to treat NSCLC and melanomas with abnormal BRAF genes. In cancer, cells multiply uncontrolled and abnormally. Talk to your physician if you have any liver problems, kidney problems, heart problems, eye problems, breathing problems, gastrointestinal disorders, or have had a different type of cancer before taking this medication. It is not recommended for adolescents and children under the age of 18. Rafinlar 75mg Capsule may impair fertility. Before starting the treatment, talk to your physician about options to improve your chances of having children.
Active Pharmaceutical Ingredient
Uses
• Melanoma
• Non-small cell lung cancer
Benefits
The therapeutic effect of Rafinlar 75mg Capsule is inhibiting the BRAF protein, which plays a crucial role in the signaling pathway that leads to uncontrolled cell growth in cancer cells with the BRAF mutation. By blocking the activity of the BRAF protein, this medication can slow down or stop the growth and spread of cancer cells, leading to the shrinkage of tumors and improving overall health.
Side Effects
Rafinlar 75mg Capsule can cause side effects like all medications, although not everyone who takes it will experience them.
Most Common Side Effects
• Nausea and vomiting
• Diarrhea or constipation
• Abdominal pain or discomfort
• Fatigue or weakness
• Headache
• Fever
• Chills
• Dizziness or lightheadedness
• Loss of appetite
• Dry skin or rash
• Joint pain or muscle pain
• Cough or shortness of breath
Common Side Effects
• New or worsening skin lesions or changes in skin color or texture
• Severe or persistent abdominal pain
• Signs of liver damage, such as yellowing of the skin or eyes, dark urine, or persistent nausea and vomiting
• Chest pain or heart palpitations
• Bleeding or bruising easily
• Signs of an allergic reaction, such as rash, itching, swelling, dizziness, or difficulty breathing
How To Use
Rafinlar 75mg Capsule is usually taken orally, in the form of a capsule, once or twice a day, with or without food. The dose and frequency depend on several factors, such as the individual's age, weight, overall health, and the type and stage of the cancer being treated. It should be swallowed whole with a full glass of water and not opened, crushed, or chewed. If a dose is missed, it should be taken as soon as possible unless it's almost time for the next scheduled dose, in which case the missed dose should be skipped, and the regular dosing schedule resumed. Do not double the dose to make up for missed doses.
Safety Advice
• Breast Feeding: You need to talk to your doctor if you are breastfeeding before taking Rafinlar 75mg Capsule. It may cause harm to the baby.
• Alcohol: It is recommended to avoid consuming alcohol while taking Rafinlar 75mg Capsule, as alcohol can increase the risk of certain side effects associated with the medication, such as stomach ulcers or gastrointestinal bleeding.
• Liver: Rafinlar 75mg Capsule can affect liver function, and in rare cases, it can cause liver damage, including hepatotoxicity and liver failure. Therefore, it's important to inform your healthcare professional if you have any history of liver problems, such as hepatitis or cirrhosis, before starting treatment.
• Lungs: Rafinlar 75mg Capsule can cause side effects that affect the lungs, such as cough, shortness of breath, and pneumonitis (inflammation of the lung tissue). In rare cases, it can also cause interstitial lung disease (ILD), a serious and potentially life-threatening condition.
• Driving: Patients receiving Rafinlar 75mg Capsule should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: Rafinlar 75mg Capsule is unsafe during pregnancy as it can cause fetal harm. It is recommended to avoid this medication during pregnancy.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.